taurine has been researched along with mesalamine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jung, YJ; Kim, HH; Kim, YM; Kong, HS | 1 |
Choi, B; Jeon, H; Jung, Y; Kim, H; Kim, YM; Kong, H; Neckers, L; Yang, Y | 1 |
Choi, B; Jung, Y; Kim, H; Kim, HH; Kim, Y; Kong, H; Yang, Y | 1 |
Choi, D; Han, J; Hong, S; Joo, K; Jung, Y; Kim, YM; Lee, Y | 1 |
4 other study(ies) available for taurine and mesalamine
Article | Year |
---|---|
Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Chemistry, Pharmaceutical; Colon; Drug Delivery Systems; Drug Screening Assays, Antitumor; In Vitro Techniques; Intestinal Absorption; Mesalamine; Organ Specificity; Prodrugs; Rats; Taurine | 2003 |
A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Chromatography, High Pressure Liquid; Colitis; Colon; Dose-Response Relationship, Drug; Humans; Mesalamine; NF-kappa B; Phosphorylation; Rats; Serine; Taurine; Tumor Necrosis Factor-alpha | 2006 |
Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Colitis; Colon; Drug Delivery Systems; Feces; Gastrointestinal Agents; Intestinal Absorption; Male; Mesalamine; Prodrugs; Rats; Rats, Sprague-Dawley; Sulfasalazine; Taurine; Trinitrobenzenesulfonic Acid | 2006 |
An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation.
Topics: Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Colitis; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Humans; I-kappa B Kinase; Interleukin-1beta; Mesalamine; NF-kappa B; Prodrugs; Taurine | 2009 |